Results 341 to 350 of about 12,874,292 (410)

Featured intestinal microbiota associated with hepatocellular carcinoma in various liver disease states. [PDF]

Front Immunol
Sun X, Zhou Z, Chi X, Cheng D, Zhang Y, Xu Y, Hao Y, Duan Y, Li W, Zhao Y, Liu S, Han M, Wang X, Yang S, Pan CQ, Xing H.   +15 more
europepmc   +1 more source

Lived and care experiences of chronic musculoskeletal shoulder pain in Australian adults: A qualitative study

Arthritis Care &Research, Accepted Article.
Objectives Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centred care and informing local service pathways and care guidelines or standards.
Sonia Ranelli, Joanne E. Jordan, Ilana N. Ackerman, Alison Thorpe, Jennifer G. Persaud, Linda J. Woodhouse, Jason Chua, Ben Horgan, Andrew M. Briggs   +8 more
wiley   +1 more source

Hepatocellular Carcinoma in Cystic Fibrosis Liver Disease. [PDF]

Gastro Hep Adv
Tarakji R, Sandhu S, Martin EF.
europepmc   +1 more source

Global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis burden, 1990–2021

Arthritis Care &Research, Accepted Article.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rate for site‐specific OA across 204 countries/territories were obtained from the Global Burden of Diseases Study (GBD) 2021.
Haowei Chen, Lei Si, David J Hunter, Lei Zhang, Zhe‐Sheng Chen, Xiaomeng Wang, Vicky Duong, Zhounan Zhou, Peihua Cao, Han Cen, Su'an Tang, Tianyu Chen, Houjun Xue, Zhaohua Zhu, Changhai Ding   +14 more
wiley   +1 more source

Effects of Fructose on Features of Steatotic Liver Disease in HepG2 Cells. [PDF]

Nutrients
Howes MT, King J, Rosengren RJ.
europepmc   +1 more source

Improvements in Health‐Related Quality of Life with Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post‐hoc Analysis of a Randomized Multicenter Trial

Arthritis Care &Research, Accepted Article.
Background While treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL change.
Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls   +16 more
wiley   +1 more source

Metabolic dysfunction-associated steatotic liver disease and pregnancy. [PDF]

J Clin Invest
Sarkar M, Kushner T.
europepmc   +1 more source

Association of serum osmolality with metabolic dysfunction-associated steatotic liver disease in adults. [PDF]

BMC Gastroenterol
Peng L, Ai M.
europepmc   +1 more source

Hyperammonemic Encephalopathy after Bariatric Surgery: A Two-Hit Vulnerability in Liver Disease. [PDF]

Clin Transl Gastroenterol
Abdulrasak M, Mohrag M, Someili AM.
europepmc   +1 more source

The gut-liver axis in progressive steatotic liver disease: A focus on bile acid dysregulation. [PDF]

J Nutr Health Aging
Louca P, Pericàs JM, Lin Y, Kouraki A, Estévez-Vázquez O, Martínez-Gómez M, Cusidó MS, Simpson JP, Cubero FJ, Homer NZM, Valdes AM, Menni C.   +11 more
europepmc   +1 more source